{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Ledgewood",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97183",
      "recalling_firm": "Imprimis NJOF, LLC",
      "address_1": "1705 Route 46 Ste 6B",
      "address_2": "N/A",
      "postal_code": "07852-9720",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0535-2025",
      "product_description": "Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705  Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01",
      "product_quantity": "6,880 vials",
      "reason_for_recall": "Sub-Potent Drug: Subpotent assay results during stability testing.",
      "recall_initiation_date": "20250709",
      "center_classification_date": "20250721",
      "report_date": "20250730",
      "code_info": "Lot: 24DEC017, Exp. 07/12/2025."
    }
  ]
}